It looks like your are using Internet Explorer.

Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.

To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

Sprint: Pharma Sales Model for DTx-Drug Combination (Part 1)

6th December @ 10:45AM EDT

While the combination of a drug with a DTx can increase the treatment value, there are many challenges when trying to fit these combinations into the pharma traditional sales model. What are the main obstacles and what would a good sales model look like for DTx+drug combinations? In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. At the end of the session, HealthXL will put together an output with the learnings from the group.    

Some of the major challenges we may tackle (these are some examples - the group will agree on the problems they want to address):  


  • Rethinking sales teams incentives: incentivizing salesforce teams to sell DTx.
  • Finding the right talent and/or upskilling existing teams  
  • Lack of a measurable ROI, figuring out a sustainable sales model for profitability.
  • Going beyond the traditional pharma sales model: how to make room to test more innovative sales models?
  • Showing sufficient data to support the product: building a compelling storytelling when selling to physicians.

Please note Part 2 of this session takes place on December 21st.


We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

Apply to Attend

Thank you! Your submission has been received.

An invite invite link has been sent to you if you do not already have a HealthXL account.
Oops! Something went wrong while submitting the form.

Sprint: Pharma Sales Model for DTx-Drug Combination (Part 1)

John Cairns
Global Head of Digital, Oncology Franchise, Sanofi
Susanna Brandi
Associate Director at Merck KGaA, Darmstadt, Germany
Apply to Attend

Sprint: Pharma Sales Model for DTx-Drug Combination (Part 1)

No items found.

Join this HealthXL Event today:

Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.


You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.

6th December @ 10:45AM EDT

While the combination of a drug with a DTx can increase the treatment value, there are many challenges when trying to fit these combinations into the pharma traditional sales model. What are the main obstacles and what would a good sales model look like for DTx+drug combinations? In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. At the end of the session, HealthXL will put together an output with the learnings from the group.    

Some of the major challenges we may tackle (these are some examples - the group will agree on the problems they want to address):  


  • Rethinking sales teams incentives: incentivizing salesforce teams to sell DTx.
  • Finding the right talent and/or upskilling existing teams  
  • Lack of a measurable ROI, figuring out a sustainable sales model for profitability.
  • Going beyond the traditional pharma sales model: how to make room to test more innovative sales models?
  • Showing sufficient data to support the product: building a compelling storytelling when selling to physicians.

Please note Part 2 of this session takes place on December 21st.


We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

Apply to AttendRegister to AttendApply to Attend

Participants

Participants

John Cairns

Global Head of Digital, Oncology Franchise, Sanofi

Susanna Brandi

Associate Director at Merck KGaA, Darmstadt, Germany

Maxime Champain

Lead, BDH External Innovation & Alliances, Search & Evaluation, Biogen

Evgueni Ivanov

Director, Digital Healthcare Transformation at UCB

Ivan Jurisic

Founder/Business Consultant, Patients Influence

Ashley Pippin

Director, Digital Product Delivery, Novartis Biome

Nick Mageras

Principal, IQVIA

Jeff Wandzura

CEO, KEEP Labs

Gandolf Finke

Founder & MD at Mika / Fosanis

Matt Norton

Vice President of Marketing & Commercial Development at S3 Connected Health

Doug Burgener

Marketing Director, Biofourmis

Ameya Phadke

Patient Non Pharma Solutions Leader - Chiesi Group

Grégoire Guillet

Chief Business and Value Officer, WeHealth Digital Medicine

Caroline Peel

VP Global Accounts, BrightInsight

Cathy Zaremba

Director of Product Marketing, BrightInsight

Number of Participants


Up to 12
Date  
December 6, 2022
Community

Sprint: Pharma Sales Model for DTx-Drug Combination (Part 1)

While the combination of a drug with a DTx can increase the treatment value, there are many challenges when trying to fit these combinations into the pharma traditional sales model. What are the main obstacles and what would a good sales model look like for DTx+drug combinations? In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. At the end of the session, HealthXL will put together an output with the learnings from the group.    

Some of the major challenges we may tackle (these are some examples - the group will agree on the problems they want to address):  


  • Rethinking sales teams incentives: incentivizing salesforce teams to sell DTx.
  • Finding the right talent and/or upskilling existing teams  
  • Lack of a measurable ROI, figuring out a sustainable sales model for profitability.
  • Going beyond the traditional pharma sales model: how to make room to test more innovative sales models?
  • Showing sufficient data to support the product: building a compelling storytelling when selling to physicians.

Please note Part 2 of this session takes place on December 21st.


We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

Participate in the Meeting

HealthXL Roundtables

HealthXL community meetings connect senior leaders from around the world.

Our virtual Roundtables are small, participant-led discussions where the HealthXL community discuss digital health challenges and offer solutions.

Participant-Led

HealthXL community members lead discussion on a defined topic among a maximum of 12 participants. There is no audience and no recordings, just an interactive space to reflect and share learnings.

Developed for a Busy Schedule

At 60-minutes long, roundtables are long enough for meaningful discussion among peers, but short enough to fit into busy schedules.

Check out our platform for the full HealthXL experience

Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:

  • Join any virtual and in-person events
  • Invite peers to meetings
  • Network
  • Gain full access to all articles and HealthXL reports
  • Get personalised recommendations
  • Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
  • Full access to community insights and meeting takeaway reports

HealthXL Masterclasses

HealthXL community events give unparalleled access to digital health leaders from around the world.

Our virtual Masterclasses are 60-minute sessions where a recognised expert in their field provides an in-depth learning experience to a small audience of 8-12 members.

EXPERT-Led

HealthXL Masterclasses give you a chance to join a small group of peers and ask questions of recognised experts in a private, convenient setting.

Check out our platform for the full HealthXL experience

Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:

  • Join any virtual and in-person events
  • Invite peers to meetings
  • Network
  • Gain full access to all articles and HealthXL reports
  • Get personalised recommendations
  • Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
  • Full access to community insights and meeting takeaway reports

HealthXL Webinars

HealthXL community events give unparalleled access to digital health experts from around the world.

Our webinars bring together panels of 3-4 global leaders from the HealthXL community to discuss core trends in digital health.

Expert Panel Discussion

Gain insights on the latest topics in digital health and ask questions of the expert panel via chat. Webinars run for 60 minutes and recordings are shared with all attendees afterwards.

Check out our platform for the full HealthXL experience

Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:

  • Join any virtual and in-person events
  • Invite peers to meetings
  • Network
  • Gain full access to all articles and HealthXL reports
  • Get personalised recommendations
  • Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
  • Full access to community insights and meeting takeaway reports
Virtual Digital Health Meeting

Join from anywhere

No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.

Apply to Attend now

The world of Digital Health in one Hub

Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers. 

As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.

Our community is growing fast. Don’t miss out on your opportunity to lead the future.


Join the community here
Reports & Insights
Reports and insights shared by the DTx community
Curated
News
Daily DTx News Curated by our in-house experts
Lists & Dashboards
Interactive dashboards and downloadable organisation data

Your Digital Health Corner

All Posts
Commentary
February 16, 2024
Tess’ Top Takes from this Month’s Meetings in Digital Health: February 2024
Tess’ Top Takes from this Month’s Meetings in Digital Health: February 2024
Read More
Commentary
February 9, 2024
Is There a Space for Digital Health in the World of RNA Based Therapeutics?
Is There a Space for Digital Health in the World of RNA Based Therapeutics?
Read More
Commentary
February 2, 2024
AI in Clinical Trials: Navigating the Trial-and-Error Process
AI in Clinical Trials: Navigating the Trial-and-Error Process
Read More

Sprint: Pharma Sales Model for DTx-Drug Combination (Part 1)

6th December @ 10:45AM EDT
Digital Therapeutics (DTx)

Sprint: Pharma Sales Model for DTx-Drug Combination (Part 1)

6th December @ 10:45AM EDT
Digital Therapeutics (DTx)
John Cairns
Global Head of Digital, Oncology Franchise, Sanofi
LinkedIn Profile
Susanna Brandi
Associate Director at Merck KGaA, Darmstadt, Germany
LinkedIn Profile
Maxime Champain
Lead, BDH External Innovation & Alliances, Search & Evaluation, Biogen
LinkedIn Profile
Evgueni Ivanov
Director, Digital Healthcare Transformation at UCB
LinkedIn Profile
Ivan Jurisic
Founder/Business Consultant, Patients Influence
LinkedIn Profile
Ashley Pippin
Director, Digital Product Delivery, Novartis Biome
LinkedIn Profile
Nick Mageras
Principal, IQVIA
LinkedIn Profile
Jeff Wandzura
CEO, KEEP Labs
LinkedIn Profile
Gandolf Finke
Founder & MD at Mika / Fosanis
LinkedIn Profile
Matt Norton
Vice President of Marketing & Commercial Development at S3 Connected Health
LinkedIn Profile
Doug Burgener
Marketing Director, Biofourmis
LinkedIn Profile
Ameya Phadke
Patient Non Pharma Solutions Leader - Chiesi Group
LinkedIn Profile
Grégoire Guillet
Chief Business and Value Officer, WeHealth Digital Medicine
LinkedIn Profile
Caroline Peel
VP Global Accounts, BrightInsight
LinkedIn Profile
Cathy Zaremba
Director of Product Marketing, BrightInsight
LinkedIn Profile

Sprint: Pharma Sales Model for DTx-Drug Combination (Part 1)

While the combination of a drug with a DTx can increase the treatment value, there are many challenges when trying to fit these combinations into the pharma traditional sales model. What are the main obstacles and what would a good sales model look like for DTx+drug combinations? In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. At the end of the session, HealthXL will put together an output with the learnings from the group.    

Some of the major challenges we may tackle (these are some examples - the group will agree on the problems they want to address):  


  • Rethinking sales teams incentives: incentivizing salesforce teams to sell DTx.
  • Finding the right talent and/or upskilling existing teams  
  • Lack of a measurable ROI, figuring out a sustainable sales model for profitability.
  • Going beyond the traditional pharma sales model: how to make room to test more innovative sales models?
  • Showing sufficient data to support the product: building a compelling storytelling when selling to physicians.

Please note Part 2 of this session takes place on December 21st.


We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

When:
6th December @ 10:45AM EDT
Apply to attend
Registration Closed

Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.

All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.

Frequently asked questions: 

What are HealthXL Virtual Meetings?

HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

How can I connect with other digital health leaders?

HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.

What are the benefits of being a HealthXL community member?

As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.

Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.